AEMD
AETHLON MEDICAL INC (AEMD
NASDAQ · Healthcare · Medical - Devices · US
$6.48
−4.42%Price chart
Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$6.40
From 52W high−83.78%
Volume2.41M
Market cap$10.39M
P/E (TTM)—
P/S (TTM)—
Div yield—
Key dataSep 18, 2026
Open
$6.40
From 52W high
−83.78%
Volume
2.41M
Market cap
$10.39M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.9x
P/E (TTM)
—
RSI (14)
74.6
MomentumView details →
1D Return
−4.42%
YTD Return
−56.25%
SummaryUpdated Jun 1, 2026
Aethlon Medical, Inc. (NASDAQ:AEMD) is a medical technology company founded in 1999 and based in San Diego, California. The company went public in March 1999 and focuses on developing innovative blood filtration devices to treat life-threatening diseases. Aethlon operates as a clinical-stage company with its flagship product, the Hemopurifier, currently undergoing various clinical trials for cancer treatment and viral infections. The company has no commercial revenue from product sales and remains in the research and development phase, funded primarily through equity raises and government contracts.
Similar companies
Latest newsMore news →
Aethlon Medical Inc. shares dropped on Friday, pulling back after surging more than 300% the previous day.2d agoHalper Sadeh LLC announced it is investigating whether Aethlon Medical, Inc. is obtaining a fair price for shareholders in its merger with North Immunology, Inc.3d agoAn oversubscribed $180 million private placement is expected to fund the combined Aethlon Medical-North Immunology company's operations into the second half of 2028.3d ago